Internal Medicine, Pulmonary Disease · Pembroke Pines, FL
NPI
1386646966
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1601 N Palm Ave, Suite 109
Pembroke Pines, FL, 33026
Phone (954) 271-0411
Groups this clinician bills Medicare through
Medicare paid, 2024
$155K
1,896 services
Medicare patients, 2024
398
Average age 75
Drug cost, 2024
$2.2M
4,645 prescriptions
Company payments, 2025
$2,674
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan C Rodriguez was code 99233 (hospital e&m - subsequent), 569 times for 119 patients. In total Juan C Rodriguez billed 1,896 services in 20 codes, and Medicare paid $155K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 569 | 119 | $98.63 | $56K |
| 99214 Office E&M - Established | Office | 321 | 187 | $102.23 | $33K |
| 94726 Pulmonary Function Testing | Office | 126 | 124 | $45.49 | $5,732 |
| 94060 Pulmonary Function Testing | Office | 126 | 124 | $31.00 | $3,906 |
| 94729 Pulmonary Function Testing | Office | 126 | 124 | $45.17 | $5,692 |
| 99223 Hospital E&M - Initial | Facility | 111 | 98 | $144.05 | $16K |
| 99213 Office E&M - Established | Office | 107 | 91 | $71.13 | $7,610 |
| 99232 Hospital E&M - Subsequent | Facility | 104 | 73 | $65.55 | $6,817 |
| 99231 Hospital E&M - Subsequent | Facility | 94 | 82 | $41.54 | $3,905 |
| 99204 Office E&M - New | Office | 74 | 74 | $134.64 | $9,964 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 38 | 37 | $13.68 | $520 |
| 95800 Sleep Study | Office | 29 | 29 | $109.71 | $3,182 |
| 94618 Pulmonary Function Testing | Office | 22 | 22 | $26.91 | $592 |
| 94729 Pulmonary Function Testing | Facility | 13 | 13 | $7.24 | $94.13 |
| 94727 Pulmonary Function Testing | Facility | 13 | 13 | $9.67 | $126 |
By year: 2022 $187K for 2,549 services; 2023 $169K for 2,139 services; 2024 $155K for 1,896 services.
Medicare prescription drug claims, 2024
In 2024, the drug Juan C Rodriguez prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,373 prescriptions and refills. In total Juan C Rodriguez wrote 4,645 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,373 | 2,581 | 550 | $74K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 569 | 1,118 | 182 | $701K |
| Breo Ellipta Fluticasone/Vilanterol | 390 | 696 | 149 | $272K |
| Montelukast Sodium Generic | 381 | 1,108 | 150 | $3,963 |
| Fluticasone Propionate Generic | 250 | 400 | 107 | $2,996 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 230 | 430 | 76 | $268K |
| Ventolin Hfa Albuterol Sulfate | 224 | 354 | 82 | $21K |
| Roflumilast Generic | 147 | 169 | 33 | $6,542 |
| Prednisone Generic | 136 | 137 | 84 | $376 |
| Symbicort Budesonide/Formoterol Fumarate | 130 | 227 | 56 | $51K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 91 | 161 | 34 | $75K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 63 | 116 | 26 | $18K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 60 | 68 | 18 | $9,338 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 53 | 140 | 23 | $12K |
| Azelastine Hcl Generic | 46 | 104 | 27 | $1,223 |
Brand drugs: 3,120 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan C Rodriguez $2,674 ($2,674 in general payments such as food, travel and fees) from 21 companies. The largest payer was GlaxoSmithKline, LLC. with $463.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 22 | $463 |
| AstraZeneca Pharmaceuticals LP AZN | 20 | $431 |
| Mallinckrodt Hospital Products Inc. | 10 | $316 |
| Genzyme Corporation SNY | 6 | $230 |
| Insmed, Inc. INSM | 7 | $217 |
| Harmony Biosciences LLC HRMY | 4 | $192 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $149 |
| Viatris Specialty LLC | 4 | $99.96 |
| Merck Sharp & Dohme LLC MRK | 3 | $92.14 |
| Amgen Inc. AMGN | 4 | $81.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.